Goserelin, an LH-RH Agonist, in the Treatment of Women With Fibrocystic Mastopathy. a Pilot Study

Summary

Summary

Twenty, mostly premenopausal, patients suffering from fibrocystic mastopathy were enrolled in a pilot study of a monthly injection of goserelin depot, an LH-RH agonist. This hormone treatment inhibits the hypothalamopituitary axis in premenopausal as well as in postmenopausal women and caused improvement in subjective complaints and objective clinical and radiological signs of mastopathy in this group of patients. LH-RH agonists might represent a useful new approach to the treatment of this syndrome and warrant further clinical investigation.